As per the research report, the size of the Asia Pacific Articaine Hydrochloride market was valued at USD 0.17 billion in 2020 and is expected to reach USD 0.26 billion by 2025 to grow at 8.43% CAGR during the forecast period 2020 to 2025.
Articaine is a form of an amide local anesthetic that is most commonly used in dentistry. This drug is originally known as carticaine. It has a different molecular structure with a thiophene ring instead of the usual benzene ring present in the other amide anesthetic drugs.
Articaine hydrochloride is an amide local anesthetic that has its major applications in dentistry. The increasing incidence of dental disorders is creating huge scope for dentists resulting in high revenue. The number of patients approaching the dentists is soaring as a result the pressure on the articaine hydrochloride market is rising rapidly resulting in the improvement in the effectiveness of the articaine. In oral surgeries, the use of articaine hydrochloride is the first preference for professionals due to its quicker effect. It is associated with less number of failures and also provides anesthesia in cases where other anesthetics fail.
This research report segmented and sub-segmented into the following categories:
Asia Pacific is expected to witness the highest CAGR in the coming years.
The Top companies leading in the APAC Articaine Hydrochloride Market profiled in the report are 3M, Anhui BBCA Pharmaceutical Co., Ltd., Dentsply Sirona, Inibsa Dental S.L.U, Jinan Chenghui Shuangda Chemical Co., Ltd, Jinan Ruixing Pharmaceutical Technology Co., Ltd, Manus Aktteva Biopharma LLP, Pfizer Inc, Pierrel S.p.A, Sanofi, Septodont, Siegfried AG, and Sigma Aldrich.
1. Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 Epidemology
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 Application
5.1.1 Introduction
5.1.2 Infiltration
5.1.3 Nerve Block
5.1.4 Others
5.1.5 Y-o-Y Growth Analysis, By Application
5.1.6 Market Attractiveness Analysis, By Application
5.1.7 Market Share Analysis, By Application
5.2 End User
5.2.1 Introduction
5.2.2 Dental Clinics
5.2.3 Hospitals
5.2.4 Academic and Research Institutes
5.2.5 Y-o-Y Growth Analysis, By End User
5.2.6 Market Attractiveness Analysis, By End User
5.2.7 Market Share Analysis, By End User
6. Geographical Analysis
6.1 Introduction
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
6.1.3.1 By Geographical Area
6.1.3.2 By Application
6.1.3.3 By End User
6.1.4 Market Attractiveness Analysis
6.1.4.1 By Geographical Area
6.1.4.2 By Application
6.1.4.3 By End User
6.1.5 Market Share Analysis
6.1.5.1 By Geographical Area
6.1.5.2 By Application
6.1.5.3 By End User
6.2 China
6.3 India
6.4 Japan
6.5 South Korea
6.6 Australia
7. Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8. Market Leaders' Analysis
8.1 3M
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 Anhui BBCA Pharmaceutical Co.Ltd.
8.3 Dentsply Sirona
8.4 Inibsa Dental S.L.U
8.5 Jinan Chenghui Shuangda Chemical Co.Ltd
8.6 Jinan Ruixing Pharmaceutical Technology Co.Ltd
8.7 Manus Aktteva Biopharma LLP
8.8 Pfizer Inc
8.9 Pierrel S.p.A
8.10 Sanofi
9. Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10. Market Outlook and Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
Related Reports
